Accenture Invests in Virtonomy to Help Medical Technology Companies Use Digital Twin Technology to Accelerate Time to Market for Medical Devices

MUNICH and NEW YORK; April 12, 2023 – Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in Virtonomy, a provider of data-driven simulations that use existing patient data and digital twin technology to bring life-saving medical devices to market more quickly. Accenture’s investment will help Virtonomy further extend its capabilities to medical technology (MedTech) companies across the globe and power the future of medical device design.